Statement Regarding A Decision By Glaxosmithkline To Release Paxil Clinical Data

Attorney General Spitzer today issued the following statement in response to a decision by GlaxoSmithKline to release clinical data regarding the safety and effectiveness of its antidepressant drug Paxil. Spitzer sued the company on June 2 alleging that the company misled doctors about the drug.

"This is a positive first step toward changing a dangerous industry practice. We can no longer permit GSK and other pharmaceutical companies to selectively choose what research to make available to physicians and the public. It is unacceptable for companies like GSK to divulge favorable results while hiding negative data when the health of patients is at stake. While today's development by GSK does not resolve all of the issues in our litigation it does represent movement in the right direction."

sitemap Intergov foil PressOffice RegionalOffices SolicitorGeneral AppealsandOpinions ConvictionBureau Investigations TaxpayerProtection PublicIntegrity MFCU OCTF CrimPros AIFU Antitrust ConsumerFrauds Internet InvestorProtection RealEstateFinance Charities CivilRights Environment HealthCare Labor Tobacco CivilRecoveries Claims Litigation RealProperty SOMB Budget LegalRecruitment Human Resources Bureau